新城疫病毒/FMW 毒株诱导卵巢癌细胞凋亡的作用研究

王娜 ,  曹玉凯 ,  冯奇东 ,  杜莎 ,  孟松树 ,  王逸菲

大连医科大学学报 ›› 2026, Vol. 48 ›› Issue (3) : 199 -207.

PDF (5615KB)
大连医科大学学报 ›› 2026, Vol. 48 ›› Issue (3) : 199 -207. DOI: 10.11724/jdmu.2026.03.02
论著

新城疫病毒/FMW 毒株诱导卵巢癌细胞凋亡的作用研究

作者信息 +

Study on the apoptosis-inducing effect of Newcastle disease virus FMW on ovarian cancer cells

Author information +
文章历史 +
PDF (5749K)

摘要

目的 探讨新城疫病毒(NDV)/FMW 毒株对人卵巢癌细胞凋亡的诱导作用。方法 所有实验均设置感染组与对照组。感染组为加入 NDV/FMW 的培养基,对照组为不加病毒的培养基。使用 NDV/FMW[感染复数(MOI)=10]感染 5 种人卵巢癌细胞(Hey、Hey-A8、TOV-112D、OVCAR-3、A2780),感染 48 h 后,显微镜观察细胞形态、台盼蓝染色统计细胞死亡率、采用蛋白质免疫印迹(Western blot)检测 HN 蛋白表达,筛选感染效率最高的细胞开展后续实验;采用 CCK-8 法检测不同 MOI(MOI=0.01、0.1、1、10)NDV/FMW 感染细胞后,24、48、72 h 时点的细胞增殖活力变化;Western blot 检测 NDV/FMW(MOI=1)感染细胞后,0、24、48 h 时点细胞凋亡关键执行蛋白包括腺苷二磷酸核糖聚合酶(PARP)及其剪切体 (cleaved-PARP)、半胱天冬蛋白酶 -3(caspase-3)及其剪切体(cleaved-caspase-3)的表达水平;Hoechst 33342 荧光染色观察不同 MOI(MOI=0.01、0.1、1、10)NDV/FMW 感染后,24、48、72 h 时点细胞核凋亡形态改变并统计凋亡细胞比例。结果 5 种人卵巢癌细胞系中,Hey 和 Hey-A8 细胞系是感染 NDV/FMW 后,死亡率最高以及 HN 表达量最高,即感染效率最高的两个细胞系,遂用作后续实验的细胞模型。Hey 细胞系:感染 48 h 后,与对照组相比, MOI=1、10 感染组增殖减弱;感染 72 h 后,与对照组相比,MOI=0.01、1、10 感染组增殖均减弱。 Hey-A8 细胞系:感染 24 h 后,与对照组相比,MOI=1、10 感染组增殖减弱;感染 48 h 及 72 h 后,与对照组相比, MOI=0.01、0.01、1、10 感染组增殖均减弱。Western blot 结果显示,感染 48 h 后,Hey、Hey-A8 两种细胞内 cleaved-caspase-3、cleaved-PARP 蛋白相对表达量较各自对照组均上调( P<0.05),而 caspase-3、PARP 总蛋白水平降低(P<0.05)。 Hoechst 33342 荧光染色结果显示,Hey 及 Hey-A8 细胞系感染组在感染 48 h 及 72 h 出现明显的核凝集、核碎裂及凋亡小体形成等典型凋亡形态特征。与各时点的对照组比较,各感染组的细胞凋亡率均明显升高,且随着 MOI 的增加,细胞凋亡率逐渐明显升高(P<0.05)。结论 NDV/FMW 可能通过激活 caspase-3/PARP 凋亡通路诱导人卵巢癌细胞凋亡,为其作为溶瘤病毒应用于卵巢癌的联合治疗提供了理论依据。

Abstract

Objective To investigate the induction of apoptosis in human ovarian cancer cells by FMW strain of Newcastle disease virus (NDV). Methods Two groups were established: an infection group, in which cells were cultured with medium supplemented with NDV/FMW, and a control group, which received virus-free medium. Five human ovarian cancer cell lines (Hey, Hey-A8, TOV-112D, OVCAR-3, and A2780) were infected with NDV/FMW at a multiplicity of infection (MOI) of 10. After 48 hours of infection, cell morphology was observed under microscopy, cell death rate was determined by trypan blue staining, and HN protein expression was analyzed by Western blot to identify the cell lines with the highest infection efficiency for subsequent experiments. Cell proliferation activity was assessed using the CCK-8 assay at 24, 48, and 72 hours post-infection with different MOIs (0.01, 0.1, 1, and 10). Western blot analysis was performed to detect the expression levels of key apoptotic execution proteins-poly (ADP-ribose) polymerase (PARP), cleaved-PARP, caspase-3, and cleaved-caspase-3-at 0, 24, and 48 hours after NDV/FMW (MOI=1) infection. Hoechst 33342 fluorescent staining was used to observe nuclear morphological changes associated with apoptosis and to quantify the proportion of apoptotic cells at 24, 48, and 72 hours following infection with different MOIs (0.01, 0.1, 1, and 10). Results Among the five human ovarian cancer cell lines, Hey and Hey-A8 showed the highest cell death rates and HN protein expression after NDV/FMW infection, indicating the highest infection efficiency, and were therefore selected as models for further studies. In the Hey cell line, compared to the control group, proliferation was significantly reduced at 48 hours post-infection with MOI=1 and 10; at 72 hours, proliferation was reduced in all groups with MOI=0.01, 1, and 10. In the Hey-A8 cell line, proliferation was decreased at 24 hours with MOI=1 and 10; at 48 and 72 hours, proliferation was reduced across all MOI groups (0.01, 0.1, 1, and 10). Western blot studies revealed that at 48 hours post-infection, the relative expression levels of cleaved-caspase-3 and cleaved-PARP were significantly upregulated in both Hey and Hey-A8 cells compared to the control group (P<0.05), while total caspase-3 and PARP protein levels were correspondingly downregulated (P<0.05). Hoechst staining showed typical apoptotic features-including nuclear condensation, fragmentation, and apoptotic body formation-in the infected Hey and Hey-A8 cell lines at 48 and 72 hours post-infection. Compared to their respective controls at each time point, the apoptotic rates in all infected groups were significantly increased, and this increase became more pronounced with higher MOI (P<0.05). Conclusion NDV/FMW may induce apoptosis in human ovarian cancer cells by activating the caspase-3/PARP apoptotic pathway, providing a theoretical basis for its potential use as an oncolytic virus in combination therapy for ovarian cancer.

关键词

新城疫病毒 / 人卵巢癌细胞 / 细胞凋亡 / 细胞增殖

Key words

Newcastle disease virus / human ovarian cancer cells / apoptosis / cell proliferation

引用本文

引用格式 ▾
王娜,曹玉凯,冯奇东,杜莎,孟松树,王逸菲. 新城疫病毒/FMW 毒株诱导卵巢癌细胞凋亡的作用研究[J]. 大连医科大学学报, 2026, 48(3): 199-207 DOI:10.11724/jdmu.2026.03.02

登录浏览全文

4963

注册一个新账户 忘记密码

参考文献

[1]

Webb PM, Jordan SJ. Global epidemiology of epithelial ovarian cancer[J]. Nat Rev Clin Oncol, 2024, 21(5): 389-400. DOI: 10.1038/s41571-024-00881-3.

[2]

Khanlarkhani N, Azizi E, Amidi F, et al. Metabolic risk factors of ovarian cancer: a review[J]. JBRA Assist Reprod, 2021: 335-347. DOI: 10.5935/1518-0557.20210067.

[3]

Pawar A, Chowdhury OR, Chauhan R, et al. Identification of key gene signatures for the overall survival of ovarian cancer[J]. J Ovarian Res, 2022, 15(1): 12. DOI: 10.1186/s13048-022-00942-0.

[4]

Kuroki L, Guntupalli SR. Treatment of epithelial ovarian cancer[J]. Bmj, 2020: m3773. DOI: 10.1136/bmj.m3773.

[5]

Trimbos JB. Surgical treatment of early-stage ovarian cancer[J]. Best Pract Res Clin Obstet Gynaecol, 2017, 41: 60-70. DOI: 10.1016/j.bpobgyn.2016.10.001.

[6]

Elyashiv O, Wong YNS, Ledermann JA. Frontline maintenance treatment for ovarian cancer[J]. Curr Oncol Rep, 2021, 23(8): 97. DOI: 10.1007/s11912-021-01088-w.

[7]

Xu XB, Lai YY, Hua ZC. Apoptosis and apoptotic body: disease message and therapeutic target potentials[J]. Biosci Rep, 2019, 39(1): BSR20180992. DOI: 10.1042/BSR20180992.

[8]

Moyer A, Tanaka K, Cheng EH. Apoptosis in cancer biology and therapy[J]. Annu Rev Pathol Mech Dis, 2025, 20: 303-328. DOI: 10.1146/annurev-pathmechdis-051222-115023.

[9]

Song H, Zhong LP, He J, et al. Application of Newcastle disease virus in the treatment of colorectal cancer[J]. World J Clin Cases, 2019, 7(16): 2143-2154. DOI: 10.12998/wjcc.v7.i16.2143.

[10]

Ye T, Jiang K, Wei L, et al. Oncolytic Newcastle disease virus induces autophagy-dependent immunogenic cell death in lung cancer cells[J]. Am J Cancer Res, 2018, 8(8): 1514-1527.

[11]

Al-Ziaydi AG, Al-Shammari AM, Hamzah MI, et al. Newcastle disease virus suppress glycolysis pathway and induce breast cancer cells death[J]. VirusDisease, 2020, 31(3): 341-348. DOI: 10.1007/s13337-020-00612-z.

[12]

Yang HM, Tian JX, Zhao J, et al. The application of Newcastle disease virus (NDV): vaccine vectors and tumor therapy[J]. Viruses, 2024, 16(6): 886. DOI: 10.3390/v16060886.

[13]

Freeman AI, Zakay-Rones Z, Gomori JM, et al. Phase Ⅰ/Ⅱ trial of intravenous NDV-HUJ oncolytic virus in recurrent glioblastoma multiforme[J]. Mol Ther, 2006, 13(1): 221-228. DOI: 10.1016/j.ymthe.2005.08.016.

[14]

Davar D, Carneiro BA, Dy GK, et al. Phase Ⅰ study of a recombinant attenuated oncolytic virus, MEDI5395 (NDV-GM-CSF), administered systemically in combination with durvalumab in patients with advanced solid tumors[J]. J Immunother Cancer, 2024, 12(11): e009336. DOI: 10.1136/jitc-2024-009336.

[15]

Fu F, Zhao M, Yang YJ, et al. Antiproliferative effect of Newcastle disease virus strain D90 on human lung cancer cell line A549[J]. Oncol Res, 2011, 19(7): 323-333. DOI: 10.3727/096504011x13079697132880.

[16]

Pecora AL, Rizvi N, Cohen GI, et al. Phase Ⅰ trial of intravenous administration of PV701, an oncolytic virus, in patients with advanced solid cancers[J]. J Clin Oncol, 2002, 20(9): 2251-2266. DOI: 10.1200/JCO.2002.08.042.

[17]

Marek J, Hanesch L, Krabbe T, et al. Oncolytic virotherapy with chimeric VSV-NDV synergistically supports RIG-Ⅰ-dependent checkpoint inhibitor immunotherapy[J]. Mol Ther Oncolytics, 2023, 30: 117-131. DOI: 10.1016/j.omto.2023.08.001.

[18]

Wang XK, Shao XY, Gu L, et al. Targeting STAT3 enhances NDV-induced immunogenic cell death in prostate cancer cells[J]. J Cell Mol Med, 2020, 24(7): 4286-4297. DOI: 10.1111/jcmm.15089.

[19]

Kiraz Y, Adan A, Kartal Yandim M, et al. Major apoptotic mechanisms and genes involved in apoptosis[J]. Tumor Biol, 2016, 37(7): 8471-8486. DOI: 10.1007/s13277-016-5035-9.

[20]

Nagata S. Apoptosis and clearance of apoptotic cells[J]. Annu Rev Immunol, 2018, 36: 489-517. DOI: 10.1146/annurev-immunol-042617-053010.

基金资助

大连市生命健康领域指导计划项目(2023)

AI Summary AI Mindmap
PDF (5615KB)

0

访问

0

被引

详细

导航
相关文章

AI思维导图

/

〈 〉